Do you have comments or tips about health insurers or healthcare providers? Email me at A wave of new drug companies has emerged in the last two years that meld multiple smaller startups to either create a single new venture or a holding company with many subsidiaries. iStock; Skye Gould/Insider These "mega biotechs" are fueled by record amounts of VC flowing into the drug industry.